EuroPCR 2015: Edwards pauses Fortis TMVI, TAVI gains across the board
Replacement heart valves once again take center stage at the annual EuroPCR conference in Paris this week, as Edwards Lifesciences pauses its Fortis trial and positive new data comes in on the next generation of aortic implants.
EuroPCRNews Well, Cardiovascular, EuroPCR 2015, Peripheral Artery Disease, Replacement Heart Valves, Stentsread more
Source: Mass Device - Category: Medical Equipment Authors: Fink Densford Source Type: news
More News: Cardiology | Cardiovascular | Conferences | Heart | Heart Valve Disease | Heart Valve Surgery | Heart Valves | Medical Devices | Peripheral Vascular Disease (PVD)